Chimeric relaxin peptides highlight the role of the A-chain in the function of H2 relaxin

Peptides

Volumn 35, Issue 1, 2012, Pages 102-106

  Hossain, Mohammed Akhter ^a   Wade, John D ^a   Bathgate, Ross A D ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

GPCR; Peptide; Relaxin; RXFP1

Indexed keywords

CHIMERIC PROTEIN; G PROTEIN COUPLED RECEPTOR; H1A RELAXIN; H2 RELAXIN; H2B RELAXIN; H3A RELAXIN; HUMAN GENE 2 RELAXIN; PEPTIDE DERIVATIVE; RELAXIN; RELAXIN FAMILY PEPTIDE RECEPTOR 1; RELAXIN FAMILY PEPTIDE RECEPTOR 2; UNCLASSIFIED DRUG;

AMINO ACID ANALYSIS; ARTICLE; BINDING AFFINITY; BINDING ASSAY; CONTROLLED STUDY; DISULFIDE BOND; DRUG SYNTHESIS; HUMAN; HUMAN CELL; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; RECEPTOR AFFINITY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SEQUENCE HOMOLOGY; STEREOCHEMISTRY;

CYCLIC AMP; HEK293 CELLS; HUMANS; INSULIN; LIGANDS; PEPTIDE FRAGMENTS; PROTEIN BINDING; PROTEINS; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, PEPTIDE; RECOMBINANT FUSION PROTEINS; RELAXIN;

EID: 84859806494     PISSN: 01969781     EISSN: 18735169     Source Type: Journal    
DOI: 10.1016/j.peptides.2012.02.021     Document Type: Article

References (39)

1. Bani D. Relaxin: a pleiotropic hormone. General Pharmacology 1997;28:13-22. (Pubitemid 27016053)
2. Bathgate RA, Ivell R, Sanborn BM, Sherwood OD, Summers RJ. International Union of Pharmacology LVII: recommendations for the nomenclature of receptors for relaxin family peptides. Pharmacological Reviews 2006;58:7-31.
3. Bathgate RA, Lin F, Hanson NF, Otvos Jr L, Guidolin A, Giannakis C, et al. Relaxin-3: improved synthesis strategy and demonstration of its high-affinity interaction with the relaxin receptor LGR7 both in vitro and in vivo. Biochemistry 2006;45:1043-53. (Pubitemid 43122269)
4. Bathgate RA, Samuel CS, Burazin TC, Layfield S, Claasz AA, Reytomas IG, et al. Human relaxin gene 3 (H3) and the equivalent mouse relaxin (M3) gene. Novel members of the relaxin peptide family. The Journal of Biological Chemistry 2002;277:1148-57. (Pubitemid 34968862)
5. Bathgate RA, Zhang S, Hughes RA, Rosengren J, Wade JD. The structural determinants of insulin-like peptide 3 activity. Frontiers in Endocrinology 2012;3:11, doi:10.3389/fendo.2012.00011.
6. Bathgate RAD, Hsueh AJW, Sherwood OD. Physiology and molecular biology of the relaxin peptide family. In: Knobil, Neill, editors. Physiology of reproduction. San Diego: Academic Press; 2006. p. 679-768.
7. Bullesbach EE, Schwabe C. Relaxin structure. Quasi allosteric effect of the NH2-terminal A-chain helix. The Journal of Biological Chemistry 1987;262:12496-501.
8. Bullesbach EE, Schwabe C. Total synthesis of human relaxin and human relaxin derivatives by solid-phase peptide synthesis and site-directed chain combination. The Journal of Biological Chemistry 1991;266:10754-61. (Pubitemid 21906868)
9. Bullesbach EE, Schwabe C. The relaxin receptor-binding site geometry suggests a novel gripping mode of interaction. The Journal of Biological Chemistry 2000;275:35276-80.
10. Bullesbach EE, Schwabe C. The trap-like relaxin-binding site of the leucine-rich G-protein-coupled receptor 7. The Journal of Biological Chemistry 2005;280:14051-6. (Pubitemid 40517306)
11. Bullesbach EE, Yang S, Schwabe C. The receptor-binding site of human relaxin II. A dual prong-binding mechanism. The Journal of Biological Chemistry 1992;267:22957-60.
12. Chan LJ, Hossain MA, Samuel CS, Separovic F, Wade JD. The relaxin peptide family - structure, function and clinical applications. Protein and Peptide Letters 2011;18:220-9.
13. Del Borgo MP, Hughes RA, Bathgate RA, Lin F, Kawamura K, Wade JD. Analogs of insulin-like peptide 3 (INSL3) B-chain are LGR8 antagonists in vitro and in vivo. The Journal of Biological Chemistry 2006;281:13068-74. (Pubitemid 43855216)
14. Dschietzig T, Bartsch C, Baumann G, Stangl K. Relaxin - a pleiotropic hormone and its emerging role for experimental and clinical therapeutics. Pharmacology & Therapeutics 2006;112:38-56. (Pubitemid 44301484)
15. Haugaard-Jonsson LM, Hossain MA, Daly NL, Bathgate RA, Wade JD, Craik DJ, et al. Structure of the R3/I5 chimeric relaxin peptide, a selective GPCR135 and GPCR142 agonist. The Journal of Biological Chemistry 2008;283:23811-8.
16. Hossain MA, Bathgate RA, Kong CK, Shabanpoor F, Zhang S, Haugaard-Jonsson LM, et al. Synthesis, conformation, and activity of human insulin-like peptide 5 (INSL5). Chembiochem: A European Journal of Chemical Biology 2008;9:1816-22.
17. Hossain MA, Belgi A, Lin F, Zhang S, Shabanpoor F, Chan L, et al. Use of a temporary solubilizing peptide tag for the Fmoc solid-phase synthesis of human insulin glargine via use of regioselective disulfide bond formation. Bioconjugate Chemistry 2009;20:1390-6.
18. Hossain MA, Rosengren KJ, Haugaard-Jonsson LM, Zhang S, Layfield S, Ferraro T, et al. The A-chain of human relaxin family peptides has distinct roles in the binding and activation of the different relaxin family peptide receptors. The Journal of Biological Chemistry 2008;283:17287-97.
19. Hossain MA, Rosengren KJ, Samuel CS, Shabanpoor F, Chan LJ, Bathgate RA, et al. The minimal active structure of human relaxin-2. The Journal of Biological Chemistry 2011;286:37555-65.
20. Hossain MA, Rosengren KJ, Zhang S, Bathgate RA, Tregear GW, van Lierop BJ, et al. Solid phase synthesis and structural analysis of novel A-chain dicarbaanalogs of human relaxin-3 (INSL7) that exhibit full biological activity. Organic & Biomolecular Chemistry 2009;7:1547-53.
21. Hossain MA, Samuel CS, Binder C, Hewitson TD, Tregear GW, Wade JD, et al. The chemically synthesized human relaxin-2 analog, B-R13/17K H2, is an RXFP1 antagonist. Amino Acids 2010;39:409-16.
22. Hossain MA, Wade JD. The roles of the A- and B-chains of human relaxin-2 and -3 on their biological activity. Current Protein & Peptide Science 2010;11:719-24.
23. Hsu SY, Nakabayashi K, Nishi S, Kumagai J, Kudo M, Sherwood OD, et al. Activation of orphan receptors by the hormone relaxin. Science 2002;295:671-4. (Pubitemid 34111824)
24. Kuei C, Sutton S, Bonaventure P, Pudiak C, Shelton J, Zhu J, et al. R3(BDelta23 27)R/I5 chimeric peptide, a selective antagonist for GPCR135 and GPCR142 over relaxin receptor LGR7: in vitro and in vivo characterization. The Journal of Biological Chemistry 2007;282:25425-35. (Pubitemid 47372825)
25. Kumagai J, Hsu SY, Matsumi H, Roh JS, Fu P, Wade JD, et al. INSL3/Leydig insulin-like peptide activates the LGR8 receptor important in testis descent. The Journal of Biological Chemistry 2002;277:31283-6. (Pubitemid 34968925)
26. Liu C, Chen J, Kuei C, Sutton S, Nepomuceno D, Bonaventure P, et al. Relaxin-3/insulin-like peptide 5 chimeric peptide, a selective ligand for G protein-coupled receptor (GPCR)135 and GPCR142 over leucine-rich repeat-containing G protein-coupled receptor 7. Molecular Pharmacology 2005;67:231-40. (Pubitemid 40069983)
27. Liu C, Chen J, Sutton S, Roland B, Kuei C, Farmer N, et al. Identification of relaxin-3/INSL7 as a ligand for GPCR142. The Journal of Biological Chemistry 2003;278:50765-70. (Pubitemid 37548925)
28. Liu C, Eriste E, Sutton S, Chen J, Roland B, Kuei C, et al. Identification of relaxin-3/INSL7 as an endogenous ligand for the orphan G-protein-coupled receptor GPCR135. The Journal of Biological Chemistry 2003;278:50754-64. (Pubitemid 37548924)
29. Liu C, Kuei C, Sutton S, Chen J, Bonaventure P, Wu J, et al. INSL5 is a high affinity specific agonist for GPCR142 (GPR100). The Journal of Biological Chemistry 2005;280:292-300. (Pubitemid 40164992)
30. Luo X, Liu Y-L, Layfield S, Shao X-X, Bathgate RAD, Wade JD, et al. A simple approach for the preparation of mature human relaxin-3. Peptides 2010;31:2083-8.
31. O'Shaughnessy PJ, Baker P, Sohnius U, Haavisto AM, Charlton HM, Huhtaniemi I. Fetal development of Leydig cell activity in the mouse is independent of pituitary gonadotroph function. Endocrinology 1998;139:1141-6. (Pubitemid 28510133)
32. Park JI, Semyonov J, Yi W, Chang CL, Hsu SY. Regulation of receptor signaling by relaxin A chain motifs: derivation of pan-specific and LGR7-specific human relaxin analogs. The Journal of Biological Chemistry 2008;283:32099-109.
33. Scott DJ, Layfield S, Yan Y, Sudo S, Hsueh AJ, Tregear GW, et al. Characterization of novel splice variants of LGR7 and LGR8 reveals that receptor signaling is mediated by their unique low density lipoprotein class A modules. The Journal of Biological Chemistry 2006;281:34942-54. (Pubitemid 46036533)
34. Scott DJ, Tregear GW, Bathgate RA. Modeling the primary hormone-binding site of RXFP1 and RXFP2. Annals of the New York Academy of Sciences 2009;1160:74-7.
35. Shabanpoor F, Separovic F, Wade JD. The human insulin superfamily of polypeptide hormones. Vitamins and Hormones 2009;80:1-31.
36. Sudo S, Kumagai J, Nishi S, Layfield S, Ferraro T, Bathgate RA, et al. H3 relaxin is a specific ligand for LGR7 and activates the receptor by interacting with both the ectodomain and the exoloop 2. The Journal of Biological Chemistry 2003;278:7855-62. (Pubitemid 36800520)
37. Teerlink JR, Metra M, Felker GM, Ponikowski P, Voors AA, Weatherley BD, et al. Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study. Lancet 2009;373:1429-39.
38. Teichman SL, Unemori E, Dschietzig T, Conrad K, Voors AA, Teerlink JR, et al. Relaxin, a pleiotropic vasodilator for the treatment of heart failure. Heart Failure Reviews 2009;14:321-9.
39. Zhang S, Hughes RA, Bathgate RA, Shabanpoor F, Hossain MA, Lin F, et al. Role of the intra-A-chain disulfide bond of insulin-like peptide 3 in binding and activation of its receptor, RXFP2. Peptides 2010;31:1730-6.